Atlas Trials

Phase I Cabazitaxel, Mitoxantrone, and Prednisone Metastatic Castration-Resistant Prostate Cancer

Clinical trial NCT01594918 · COMPLETED

Trial details

NCT number
NCT01594918
Sponsor
Rahul Aggarwal
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic Castration-resistant Prostate Cancer
Start date
2012-06-01
Primary completion
2016-08-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.